Real-time visualization of a fluorescent G(alpha)(s): dissociation of the activated G protein from plasma membrane
A recent meta-analysis found no link between GLP-1 agonists and pancreatitis in people with Type 2 diabetes, but some case reports challenge this
A large observational study published in Nature Communications (Wang et al., 2024) followed 83,825 patients with obesity and found that GLP-1 receptor agonists, including semaglutide, were associated with a substantially lower risk of alcohol use disorder (AUD) incidence and recurrence
Emerging research suggests GLP-1 may also affect reward pathways, potentially influencing taste perception
It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism
Interaction with GLP-1 receptor-expressing neurons here produces further activation of important brain nuclei, including the paraventricular and the arcuate nucleus, the nucleus of the solitary tract and the nucleus ambiguous, the bed nucleus of stria terminalis, the central nucleus of the amygdala and the parabrachial nucleus [10]